Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAIN-STOP: NMDA Antagonists and Steroids for PPSP Prevention
NCT02950233Phase 3Terminated
- Sponsor
- Population Health Research Institute
- Start
- May 2017
- Primary completion
- Dec 2018
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of ketamine, memantine and dexamethasone in Persistent postsurgical pain (PPSP) (4 arms), sponsored by Population Health Research Institute. Primary endpoints: Recruitment Rate at 6 months and Follow-up Rate at 9 months. Started May 2017; status: terminated.
02
Drugs
ketaminememantinedexamethasone
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT02950233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02950233.